Hematologic Neoplasms: all 1,494 studies
Page 10 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)Status unknownNCT04720144
- Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic MalignanciesCompletedNCT04710212
- CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological MalignanciesStatus unknownNCT04700319Early Phase 1
- A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT04696809Phase 1/2
- Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSMCompletedNCT04695431
- Hospital at Home at EOL in Heme MalignanciesCompletedNCT04690205Not applicable
- A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological MalignanciesCompletedNCT04689204Early Phase 1
- Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).CompletedNCT04687982Not applicable
- Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid MalignanciesWithdrawnNCT04684979Phase 2
- SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological MalignanciesActive, not recruitingNCT04684108Phase 1
- B-Cell Reconstitution After Hematopoietic Stem Cell TransplantationStatus unknownNCT04682314
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCompletedNCT04681105Phase 1
- Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell TransplantActive, not recruitingNCT04678427Not applicable
- Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological MalignanciesStatus unknownNCT04673305Not applicable
- Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical TrialsActive, not recruitingNCT04650178
- Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing MalignanciesCompletedNCT04649112Phase 1
- Thrombosomes® in Bleeding Thrombocytopenic Patients StudyTerminatedNCT04631211Phase 2
- Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer PatientsTerminatedNCT04630431Not applicable
- Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and TelehealthCompletedNCT04630015
- Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT)CompletedNCT04628234
- Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin LymphomaStatus unknownNCT04626908Phase 1/2
- A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural SettingStatus unknownNCT04613765
- 64Cu-DOTA-pembrolizumab PET for the Study of PD1 ExpressionWithdrawnNCT04605614Phase 1
- Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyCompletedNCT04593277Not applicable
- Financial Toxicity in Cancer PatientsActive, not recruitingNCT04592250
- An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic MalignanciesStatus unknownNCT04581187
- Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical PneumoniaActive, not recruitingNCT04565665Phase 1/2
- Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral NeuropathyActive, not recruitingNCT04560673Phase 2
- Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home ProgramWithdrawnNCT04557709
- A Study of Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT04557098Phase 2
- A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic MalignanciesCompletedNCT04543305Phase 1
- RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic MalignanciesCompletedNCT04538599Phase 1
- Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST StudyActive, not recruitingNCT04537871
- Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic MalignanciesTerminatedNCT04504708Phase 1/2
- Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 PandemicActive, not recruitingNCT04500600
- Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI StudyWithdrawnNCT04500548Phase 1
- Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological MalignanciesStatus unknownNCT04497701Not applicable
- An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect ApplicationStatus unknownNCT04496375
- Long-term Follow-up Study for Patients Treated With CLBR001 CAR-TCompletedNCT04488354Phase 1
- Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly PatientsStatus unknownNCT04478916
- Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child NeoplasiaCompletedNCT04471961Not applicable
- HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWithdrawnNCT04464889Phase 1
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersActive, not recruitingNCT04459273Phase 1
- Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on HospiceCompletedNCT04454723Not applicable
- Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell TransplantationWithdrawnNCT04428918
- Effects of Parenteral Nutrition in HSCTCompletedNCT04425642Not applicable
- A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With CancerCompletedNCT04419623Phase 1
- A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological MalignanciesStatus unknownNCT04412577Phase 1
- The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding SpiritualityWithdrawnNCT04412135
- Remote Monitoring of Cancer Patients With Suspected Covid-19Status unknownNCT04397705Phase 1
- Early Detection of Neuropathy and Cognitive Impairment Following Treatment for Haematological MalignanciesActive, not recruitingNCT04393363
- Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)WithdrawnNCT04392128Phase 2
- Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell TherapyWithdrawnNCT04390542Not applicable
- Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision OncologyCompletedNCT04389541
- MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic MalignanciesStatus unknownNCT04370457Not applicable
- Muscle Stimulation for Physical Function During Stem Cell TransplantCompletedNCT04364256Not applicable
- COVID19-hematological Malignancies: the Italian Hematology AllianceStatus unknownNCT04352556
- A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell AllograftsWithdrawnNCT04331483Not applicable
- Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral TherapyStatus unknownNCT04327583Not applicable
- Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell TransplantStatus unknownNCT04323605Not applicable
- Natural Killer Cell (CYNK-001) Infusions in Adults with AMLTerminatedNCT04310592Phase 1
- Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological MalignanciesTerminatedNCT04305249Phase 1
- The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma PatientsCompletedNCT04303091Not applicable
- Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer PainActive, not recruitingNCT04296305Phase 4
- CAR-T Cellular Therapy for B Cell Malignancies Involved in CNSStatus unknownNCT04287309
- Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies SubjectsCompletedNCT04283097Phase 1
- CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesWithdrawnNCT04282174Phase 2
- CAR T-CELL Therapy Educational Video TrialStatus unknownNCT04280133Not applicable
- A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic MalignanciesCompletedNCT04279405Phase 1
- Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell TherapyWithdrawnNCT04275154
- Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNACompletedNCT04264767
- Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic MalignanciesStatus unknownNCT04264078Early Phase 1
- Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic MalignanciesStatus unknownNCT04264039Early Phase 1
- First-in-Human Study of ICT01 in Patients With Advanced CancerActive, not recruitingNCT04243499Phase 1/2
- Rehabilitation Needs of the Malaysian Haematological Cancer SurvivorsCompletedNCT04236063
- CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer PatientsCompletedNCT04235153
- A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignancyStatus unknownNCT04226989Early Phase 1
- A Study of AZD0466 in Patients With Advanced Hematologic or Solid TumorsTerminatedNCT04214093Phase 1
- Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging CliniciansActive, not recruitingNCT04196972Not applicable
- Treatment of Hematological Malignancy With Novel CAR-T Cells.Status unknownNCT04191941Early Phase 1
- Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH StudyCompletedNCT04188912
- Resiliency in Older Adults Undergoing Bone Marrow TransplantCompletedNCT04188678
- Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer PatientsActive, not recruitingNCT04188418Phase 3
- Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat TrialsCompletedNCT04184869Phase 1
- The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological MalignanciesStatus unknownNCT04184414Early Phase 1
- Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell TransplantActive, not recruitingNCT04177004Phase 1
- Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care UnitsCompletedNCT04174053Not applicable
- Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral NeuropathyCompletedNCT04170075Not applicable
- CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesStatus unknownNCT04156256Early Phase 1
- Tissue Microarray of Hematological MalignanciesActive, not recruitingNCT04142372
- CAR-37 T Cells in Hematologic MalignanciesCompletedNCT04136275Phase 1
- Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell TransplantationActive, not recruitingNCT04098393Phase 1
- Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular ImmunotherapyTerminatedNCT04093622
- Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep StudyActive, not recruitingNCT04089358Phase 3
- Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T CellsStatus unknownNCT04082910Phase 1/2
- First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNCT04067336Phase 1/2
- Nutritional and Physical Exercise Intervention in Older Patients With Malignant HemopathiesStatus unknownNCT04057443Not applicable
- An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic MalignanciesCompletedNCT04052126Not applicable
- Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological MalignanciesCompletedNCT04024995
- Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant PatientsStatus unknownNCT04024618Not applicable